A new approach to enhance bioavailability of biologically active peptides: conjugation of a δ opioid agonist to β-cyclodextrin
- 31 May 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (5) , 831-834
- https://doi.org/10.1016/s0960-894x(00)80675-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- An approach to vectorisation of pharmacologically active molecules: The covalent binding of leu-enkephalin to a modified β- cyclodextrin.Tetrahedron Letters, 1990
- Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerationsBiochemical Journal, 1990
- [Cyclic] [D-Pen2,D-Pen5]enkephalin analogs with increased affinity and selectivity for .delta.-opioid receptorsJournal of Medicinal Chemistry, 1990
- Synthesis and biological activity of [Leu5]enkephalin derivatives containing d‐glucoseInternational Journal of Peptide and Protein Research, 1988
- Neuropeptides and the Blood-Brain BarrierAnnual Review of Physiology, 1983
- Synthesis of chemically modified cyclodextrinsTetrahedron, 1983
- On the concept of linear modified retro-peptide structuresAccounts of Chemical Research, 1979